Market Overview:
The global polymers drug delivery market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for advanced drug delivery systems and rising prevalence of chronic diseases. In addition, the growing focus on R&D activities for novel drug delivery systems is also contributing to the growth of this market. Based on type, the global polymers drug delivery market can be segmented into micelles, microgels, dendrimers, hydrogels, and other types. The hydrogels segment is expected to grow at the highest CAGR during the forecast period owing to their high biocompatibility and ability to control release kinetics of drugs. Based on application, this market can be divided into medical research centers, pharmaceutical factories, and other applications such as hospitals and clinics. The medical research centers segment is projected to grow at a higher rate during the forecast period owingto rising demand for better treatment options for chronic diseases such as cancerand diabetes mellitus .
Product Definition:
Polymers Drug Delivery is the use of polymers to deliver drugs. This can be done through a variety of methods, such as encapsulating the drug in a polymer or coating the drug with a polymer. Polymers can also be used to create carriers that dissolve slowly, releasing the drug over time. This controlled release helps to ensure that the drugs are delivered effectively and safely to their target site.
Micelles:
Micelles are colloidal particles that are assemblies of lipids and water. They have a hydrophobic interior and an exterior coated with a bilayer membrane, which is made up of two types of lipid molecules linked by neutral fats. The exterior layer has polar heads while the interior has non-polar regions allowing the micelles to aggregate forming small clusters called micelle groups or micelles.
Microgels:
Microgels are small solid particles in a solution and they interact with the surrounding solutions to form a gel. They are made from polymers, such as polyacrylamide, which is why they are also known as polymer microgels. Microgel technology has been around for quite some time but it was only recently that their potential use in drug delivery applications started being explored.
Application Insights:
The pharmaceutical factory application segment led the market in 2017 and is projected to maintain its dominance over the forecast period. The high penetration of this application can be attributed to factors such as growing demand for drugs, increasing number of drug manufacturers, and availability of advanced manufacturing technologies.
The other applications include medical research centers and hospital laboratories. These applications are expected to witness significant growth over the forecast period owing to rising R&D activities pertaining to new drug formulations that are effective against multi-drug resistant bacteria. In addition, favorable government regulations regarding bio-production in various countries will boost industry expansion over the coming years. Polymers have a wide range of potential uses in medical devices & equipment as well as diagnostics due their biocompatibility which makes them an ideal choice for implantable devices & equipment (e.
Regional Analysis:
Asia Pacific is expected to be the fastest growing regional market over the forecast period. The growth of this region can be attributed to increasing R&D activities and rising healthcare expenditure in emerging economies such as China, India, and Japan. In addition, factors such as aging population increase in chronic diseases burden are also expected to drive demand for polymer-based drug delivery systems in Asia Pacific region.
The Asia Pacific polymers drug delivery market was valued at USD X million in 2017 owing to high unmet medical needs coupled with rapidly developing pharmaceutical industry especially due to favorable government policies aimed at promoting domestic manufacturing capabilities of drugs within a country’s borders thereby driving innovation & development of novel therapeutics and vaccines for infectious diseases including HIV/AIDS, Ebola virus disease (EVD), SARS etc., cancer among others which require urgent attention from regulatory agencies & health organizations worldwide.
Growth Factors:
- Increasing demand for polymers drug delivery systems from the pharmaceutical and biotechnology industries for targeted drug delivery.
- Growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases that require long-term treatment with drugs delivered through polymeric systems for better patient outcomes.
- Rising number of clinical trials being conducted to evaluate the efficacy and safety of novel polymeric drug delivery systems in various therapeutic areas.
- Technological advancements in polymer science that are resulting in development of new generations of polymeric drug delivery platforms with improved properties and functionality.
Scope Of The Report
Report Attributes
Report Details
Report Title
Polymers Drug Delivery Market Research Report
By Type
Micelles, Microgels, Dendrimer, Hydrogels, Other
By Application
Medical Research Center, Pharmaceutical Factory, Other
By Companies
Sanofi, Johnson & Johnson, Inovio Pharmaceuticals, Alkermes, Janssen Biotech, Heron, Eisai, Perrigo, Quark Pharmaceuticals Inc, Vectura Group Plc, SurModics, EnColl Corporation, Enzon Pharmaceuticals, Nektar Therapeutics, Allergan, Gilead Sciences, Tolmar
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Polymers Drug Delivery Market Report Segments:
The global Polymers Drug Delivery market is segmented on the basis of:
Types
Micelles, Microgels, Dendrimer, Hydrogels, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Research Center, Pharmaceutical Factory, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Johnson & Johnson
- Inovio Pharmaceuticals
- Alkermes
- Janssen Biotech
- Heron
- Eisai
- Perrigo
- Quark Pharmaceuticals Inc
- Vectura Group Plc
- SurModics
- EnColl Corporation
- Enzon Pharmaceuticals
- Nektar Therapeutics
- Allergan
- Gilead Sciences
- Tolmar
Highlights of The Polymers Drug Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Micelles
- Microgels
- Dendrimer
- Hydrogels
- Other
- By Application:
- Medical Research Center
- Pharmaceutical Factory
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polymers Drug Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Polymers drug delivery is a method of delivering drugs and other medical treatments directly to the site of treatment. Polymers are often used as carriers for medications, because they are non-toxic and have a long shelf life. They can also be used to create small, targeted doses of medication that can reach specific areas in the body. This type of delivery system is often more effective than traditional methods, such as injections or pills, because it allows doctors to target specific areas in the body with greater accuracy.
Some of the key players operating in the polymers drug delivery market are Sanofi, Johnson & Johnson, Inovio Pharmaceuticals, Alkermes, Janssen Biotech, Heron, Eisai, Perrigo, Quark Pharmaceuticals Inc, Vectura Group Plc, SurModics, EnColl Corporation, Enzon Pharmaceuticals, Nektar Therapeutics, Allergan, Gilead Sciences, Tolmar.
The polymers drug delivery market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Polymers Drug Delivery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Polymers Drug Delivery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Polymers Drug Delivery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Polymers Drug Delivery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Polymers Drug Delivery Market Size & Forecast, 2020-2028
4.5.1 Polymers Drug Delivery Market Size and Y-o-Y Growth
4.5.2 Polymers Drug Delivery Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Micelles
5.2.2 Microgels
5.2.3 Dendrimer
5.2.4 Hydrogels
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Medical Research Center
6.2.2 Pharmaceutical Factory
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Polymers Drug Delivery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Polymers Drug Delivery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Micelles
9.6.2 Microgels
9.6.3 Dendrimer
9.6.4 Hydrogels
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Medical Research Center
9.10.2 Pharmaceutical Factory
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Micelles
10.6.2 Microgels
10.6.3 Dendrimer
10.6.4 Hydrogels
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Medical Research Center
10.10.2 Pharmaceutical Factory
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Micelles
11.6.2 Microgels
11.6.3 Dendrimer
11.6.4 Hydrogels
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Medical Research Center
11.10.2 Pharmaceutical Factory
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Micelles
12.6.2 Microgels
12.6.3 Dendrimer
12.6.4 Hydrogels
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Medical Research Center
12.10.2 Pharmaceutical Factory
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Micelles
13.6.2 Microgels
13.6.3 Dendrimer
13.6.4 Hydrogels
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Medical Research Center
13.10.2 Pharmaceutical Factory
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Polymers Drug Delivery Market: Competitive Dashboard
14.2 Global Polymers Drug Delivery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Johnson & Johnson
14.3.3 Inovio Pharmaceuticals
14.3.4 Alkermes
14.3.5 Janssen Biotech
14.3.6 Heron
14.3.7 Eisai
14.3.8 Perrigo
14.3.9 Quark Pharmaceuticals Inc
14.3.10 Vectura Group Plc
14.3.11 SurModics
14.3.12 EnColl Corporation
14.3.13 Enzon Pharmaceuticals
14.3.14 Nektar Therapeutics
14.3.15 Allergan
14.3.16 Gilead Sciences
14.3.17 Tolmar
